# Comparison of Pulsed-field Gel Electrophoresis and Whole Genome Sequencing to Determine Transmission Rate of ESBL-producing E.Coli

> **NCT04323553** · — · TERMINATED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 43 (actual)

## Conditions studied

- Analysis Transmission Rate

## Interventions

- **DIAGNOSTIC_TEST:** Pulsed-field gel electrophoresis and whole genome sequencing
- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT04323553
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-06
- **Primary completion:** 2025-01-07
- **Final completion:** 2025-01-07
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** This study is no longer of interested as one of the technology used is already outdated.
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04323553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04323553, "Comparison of Pulsed-field Gel Electrophoresis and Whole Genome Sequencing to Determine Transmission Rate of ESBL-producing E.Coli". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04323553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
